Allergen-dependent solubilization of IL-13 receptor α2 reveals a novel mechanism to regulate allergy

Journal of Allergy and Clinical Immunology

Volumn 119, Issue 2, 2007, Pages 375-383

  Daines, Michael O ^a   Chen, Weiguo ^a   Tabata, Yasuhiro ^a   Walker, Bradley A ^a   Gibson, Aaron M ^a   Masino, J Alexander ^a   Warrier, Manoj R ^a   Daines, Cori L ^a   Wenzel, Sally E ^b   Hershey, Gurjit K Khurana ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

allergen; asthma; cytokine receptor; house dust mite; IL 13R 2

Indexed keywords

ALLERGEN; HOUSE DUST ALLERGEN; INTERLEUKIN 13 RECEPTOR ALPHA2; PROTEINASE;

ALLERGENICITY; ALLERGY; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DERMATOPHAGOIDES FARINAE; DERMATOPHAGOIDES PTERONYSSINUS; ENZYME ACTIVITY; EXPOSURE; HUMAN; HUMAN CELL; IMMUNOREGULATION; LUNG LAVAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RECEPTOR SOLUBILIZATION; SENSITIZATION;

ALLERGENS; ANIMALS; ASTHMA; BIOLOGICAL MARKERS; HUMANS; HYPERSENSITIVITY; INTERLEUKIN-13 RECEPTOR ALPHA2 SUBUNIT; MICE; MICE, INBRED C57BL; PROTEASE INHIBITORS; PYROGLYPHIDAE; SOLUBILITY; STAT6 TRANSCRIPTION FACTOR;

EID: 33846840988     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2006.09.039     Document Type: Article

References (36)

1. von Mutius E., Schwartz J., Neas L.M., Dockery D., and Weiss S.T. Relation of body mass index to asthma and atopy in children: the National Health and Nutrition Examination Study III. Thorax 56 (2001) 835-838
2. Aberg N., Hesselmar B., Aberg B., and Eriksson B. Increase of asthma, allergic rhinitis and eczema in Swedish schoolchildren between 1979 and 1991. Clin Exp Allergy 25 (1995) 815-819
3. Minty A., Chalon P., Derocq J.-M., Dumont X., Guillemot J.-C., Kaghad M., et al. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 362 (1993) 248-250
4. McKenzie A.N., Culpepper J.A., de Waal Malefyt R., Briere F., Punnonen J., Aversa G., et al. Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-cell function. Proc Natl Acad Sci U S A 90 (1993) 3735-3739
5. Yokota T., Otsuka T., Mosmann T., Banchereau J., DeFrance T., Blanchard D., et al. Isolation and characterization of a human interleukin cDNA clone, homologous to mouse B-cell stimulatory factor 1, that expresses B-cell- and T-cell-stimulating activities. Proc Natl Acad Sci U S A 83 (1986) 5894-5898
6. Noma Y., Sideras P., Naito T., Bergstedt-Lindquist S., Azuma C., Severinson E., et al. Cloning of cDNA encoding the murine IgG1 induction factor by a novel strategy using SP6 promoter. Nature 319 (1986) 640-646
7. Rankin J.A., Picarella D.E., Geba G.P., Temann U.A., Prasad B., DiCosmo B., et al. Phenotypic and physiologic characterization of transgenic mice expressing interleukin 4 in the lung: lymphocytic and eosinophilic inflammation without airway hyperreactivity. Proc Natl Acad Sci U S A 93 (1996) 7821-7825
8. Zhu Z., Homer R.J., Wang Z., Chen Q., Geba G.P., Wang J., et al. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 103 (1999) 779-788
9. Nakamura Y., Azuma M., Okano Y., Sano T., Takahashi T., Ohmoto Y., et al. Upregulatory effects of interleukin-4 and interleukin-13 but not interleukin-10 on granulocyte/macrophage colony-stimulating factor production by human bronchial epithelial cells. Am J Respir Cell Mol Biol 15 (1996) 680-687
10. Tang M.L., Coleman J., and Kemp A.S. Interleukin-4 and interferon-gamma production in atopic and non-atopic children with asthma. Clin Exp Allergy 25 (1995) 515-521
11. Huang S.K., Xiao H.Q., Kleine-Tebbe J., Paciotti G., Marsh D.G., Lichtenstein L.M., et al. IL-13 expression at the sites of allergen challenge in patients with asthma. J Immunol 155 (1995) 2688-2694
12. Doucet C., Brouty-Boye D., Pottin-Clemenceau C., Canonica G.W., Jasmin C., and Azzarone B. Interleukin (IL) 4 and IL-13 act on human lung fibroblasts: implication in asthma. J Clin Invest 101 (1998) 2129-2139
13. Aman M., Tayebi N., Obiri N.I., Puri R.K., Modi W.S., and Leonard W.J. CDNA cloning and characterization of the human interleukin 13 receptor alpha chain. J Biol Chem 271 (1996) 29265-29270
14. Caput D., Laurent P., Kaghad M., Lelias J.M., Lefort S., Vita N., et al. Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor alpha chain. J Biol Chem 271 (1996) 16921-16926
15. Hilton D.J., Zhang J.G., Metcalf D., Alexander W.S., Nicola N.A., and Willson T.A. Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. Proc Natl Acad Sci U S A 93 (1996) 497-501
16. Miloux B., Laurent P., Bonnin O., Lupker J., Caput D., Vita N., et al. Cloning of the human IL-13R alpha1 chain and reconstitution with the IL4R alpha of a functional IL-4/IL-13 receptor complex. FEBS Lett 401 (1997) 163-166
17. Zhang J.G., Hilton D.J., Willson T.A., McFarlane C., Roberts B.A., Moritz R.L., et al. Identification, purification, and characterization of a soluble interleukin (IL)-13-binding protein: evidence that it is distinct from the cloned Il-13 receptor and Il-4 receptor alpha-chains. J Biol Chem 272 (1997) 9474-9480
18. Guo F.H., Uetani K., Haque S.J., Williams B.R., Dweik R.A., Thunnissen F.B., et al. Interferon gamma and interleukin 4 stimulate prolonged expression of inducible nitric oxide synthase in human airway epithelium through synthesis of soluble mediators. J Clin Invest 100 (1997) 829-838
19. Wood N., Whitters M.J., Jacobson B.A., Witek J., Sypek J.P., Kasaian M., et al. Enhanced interleukin (IL)-13 responses in mice lacking IL-13 receptor alpha 2. J Exp Med 197 (2003) 703-709
20. Chiaramonte M.G., Mentink-Kane M., Jacobson B.A., Cheever A.W., Whitters M.J., Goad M.E., et al. Regulation and function of the interleukin 13 receptor alpha 2 during a T helper cell type 2-dominant immune response. J Exp Med 197 (2003) 687-701
21. Fichtner-Feigl S., Strober W., Kawakami K., Puri R.K., and Kitani A. IL-13 signaling through the IL-13alpha(2) receptor is involved in induction of TGF-beta(1) production and fibrosis. Nat Med 12 (2006) 99-106
22. Donaldson D.D., Whitters M.J., Fitz L.J., Neben T.Y., Finnerty H., Henderson S.L., et al. The murine IL-13 receptor alpha 2: molecular cloning, characterization, and comparison with murine IL-13 receptor alpha 1. J Immunol 161 (1998) 2317-2324
23. Grunig G., Warnock M., Wakil A.E., Venkayya R., Brombacher F., Rennick D.M., et al. Requirement for IL-13 independently of IL-4 in experimental asthma. Science 282 (1998) 2261-2263
24. Wills-Karp M., Luyimbazi J., Xu X., Schofield B., Neben T.Y., Karp C.L., et al. Interleukin-13: central mediator of allergic asthma. Science 282 (1998) 2258-2261
25. Schulz O., Sewell H.F., and Shakib F. Proteolytic cleavage of CD25, the alpha subunit of the human T cell interleukin 2 receptor, by Der p 1, a major mite allergen with cysteine protease activity. J Exp Med 187 (1998) 271-275
26. Schulz O., Laing P., Sewell H.F., and Shakib F. Der p I, a major allergen of the house dust mite, proteolytically cleaves the low-affinity receptor for human IgE (CD23). Eur J Immunol 25 (1995) 3191-3194
27. Levine S.J. Mechanisms of soluble cytokine receptor generation. J Immunol 173 (2004) 5343-5348
28. Daines M.O., Tabata Y., Walker B.A., Chen W., Warrier M.R., Basu S., et al. Level of expression of IL-13R alpha 2 impacts receptor distribution and IL-13 signaling. J Immunol 176 (2006) 7495-7501
29. Tabata Y., Chen W., Warrier M., Gibson A., Daines M., and Khurana Hershey G. Allergy-driven alternative splicing of interleukin-13 receptor alpha 2 yields distinct membrane and soluble forms. J Immunology (2006) In press
30. Andrews R.P., Ericksen M.B., Cunningham C.M., Daines M.O., and Hershey G.K. Analysis of the life cycle of stat6: continuous cycling of STAT6 is required for IL-4 signaling. J Biol Chem 277 (2002) 36563-36569
31. Daines M.O., and Hershey G.K. A novel mechanism by which interferon-gamma can regulate interleukin (IL)-13 responses: evidence for intracellular stores of IL-13 receptor alpha-2 and their rapid mobilization by interferon-gamma. J Biol Chem 277 (2002) 10387-10393
32. Wenzel S.E., Schwartz L.B., Langmack E.L., Halliday J.L., Trudeau J.B., Gibbs R.L., et al. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med 160 (1999) 1001-1008
33. Wenzel S.E., Szefler S.J., Leung D.Y., Sloan S.I., Rex M.D., and Martin R.J. Bronchoscopic evaluation of severe asthma: persistent inflammation associated with high dose glucocorticoids. Am J Respir Crit Care Med 156 (1997) 737-743
34. Wan H., Winton H.L., Soeller C., Tovey E.R., Gruenert D.C., Thompson P.J., et al. Der p 1 facilitates transepithelial allergen delivery by disruption of tight junctions. J Clin Invest 104 (1999) 123-133
35. Peat J.K., Tovey E., Toelle B.G., Haby M.M., Gray E.J., Mahmic A., et al. House dust mite allergens: a major risk factor for childhood asthma in Australia. Am J Respir Crit Care Med 153 (1996) 141-146
36. Gough L., Schulz O., Sewell H.F., and Shakib F. The cysteine protease activity of the major dust mite allergen Der p 1 selectively enhances the immunoglobulin E antibody response. J Exp Med 190 (1999) 1897-1902